Bharat Parenterals has informed about the meeting of the Board of Directors of the Company convened on Wednesday, 14th November, 2018 at the Registered Office of the Company to transact the business as stated in the agenda sent to the Directors and to consider and approve Un-Audited Financial Results of the Company for the quarter ended on September 30, 2018. Further, the Trading Window for dealing in the Company's securities, as required under the Code of SEBI (Prohibition of Insider Trading) Regulation, 2015 shall remain closed from November 07, 2018 to November 16, 2018.
The above information is a part of company’s filings submitted to BSE.
